Blood test may help decide who needs more lung cancer treatment
NCT ID NCT07357532
First seen Jan 29, 2026 · Last updated May 13, 2026 · Updated 13 times
Summary
This study looks at people with limited-stage small cell lung cancer whose disease is under control after standard chemotherapy and radiation. A special blood test (MRD) checks for tiny bits of cancer DNA left behind. If the test is positive, patients get a combination of immunotherapy and anti-angiogenic drugs to try to lower the risk of the cancer coming back. The goal is to see if this approach can turn the blood test negative and improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University Cancer Hospital & Institute
Beijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.